Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Article in Human Vaccines & Immunotherapeutics (May 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Human Vaccines & Immunotherapeutics (May 2024)
Article in Influenza and Other Respiratory Viruses (April 2024)
Article in Italian Journal of Pediatrics (March 2024)